3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Breast Neoplasms
5
Papillomavirus Infections
4
Uterine Cervical Neoplasms
3
Uterine Cervical Dysplasia
3
Pancreatic Neoplasms
3
Neoplasms
3
Multiple Myeloma
3
Lymphoma, Follicular
3
Triple Negative Breast Neoplasms
2
Lymphoma, Mantle-Cell
2
Lymphoma
2
Lung Neoplasms
2
Waldenstrom Macroglobulinemia
1
Thymic aplasia
1
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms
1
Pneumonia
1
Osteosarcoma
1
Obesity
1
Neurofibromatosis 1
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphohistiocytosis, Hemophagocytic
1
Interventions
Everolimus
16
Octreotide
6
pembrolizumab
5
lanreotide
5
Sunitinib
5
Magnetic Resonance Spectroscopy
5
gallium Ga 68 dotatate
4
cabozantinib
4
Nivolumab
4
Carboplatin
4
telotristat ethyl
3
lenvatinib
3
arginyllysine
3
Specimen Handling
3
Etoposide
3
Erlotinib Hydrochloride
3
Bevacizumab
3
surufatinib
2
pazopanib
2
pasireotide
2
lutetium Lu 177 dotatate
2
amino-acid, glucose, and electrolyte solution
2
X-Rays
2
Temozolomide
2
Sorafenib
2
Phantoms, Imaging
2
Paclitaxel
2
Oxaliplatin
2
Ipilimumab
2
Doxorubicin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neuroendocrine Tumors
×
Blood Specimen Collection
×
Clear all
No trials found.